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Abstract 
Pathogenic microorganisms are gradually becoming resistant to antibiotics, thereby novel antimicrobial 
technology are urgently needed. Photodynamic therapy (PDT) is a process that employs the energy of 
photons to generate reactive oxygen species through a class a chemicals known as photosensitisers. PDT has 
shown antimicrobial activity as the oxygen reactive species can inactivate microorganisms, at the same time, 
the doses required to provide antimicrobial actions are not lethal to mammalian cells. 
We covalently bound Toluidine blue O (TBO), a very common and safe photosensitiser, to silica 
nanoparticles. The conjugates exhibited antimicrobial activity against MRSA, S. epidermidis and E. coli 
when irradiated with laser light at 630 nm. Using a light source with a power of 500 mW the bacterial 
reduction exhibited a dose-response behaviour and it was 2 log10 for S. epidermidis and E. coli after 2 and 3 
min, respectively. No antimicrobial activity was exhibited by the unconjugated nanoparticles or by the laser 
light alone. The release of TBO from the nanoparticles was pH dependent with higher amounts of 
photosensitisers were detached at pH = 4 than pH = 7 consistent with the formation of amide bonds between 
nanoparticles and TBO. 
The light activated nanoparticles developed in this work offer a platform for the controlled delivery of TBO 
through a pH responsive mechanism for antimicrobial applications. 
  
1 Introduction 
Non-antibiotic based antimicrobial therapies are an urgent need in the management of infections in light of 
the rising number of microorganisms exhibiting resistance to one of more antibiotics [1]. Skin and soft-tissue 
infections (SSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) are very frequent and 
their rate has increased 20 folds in the last decade [2]; it has been estimated that every MRSA infection costs 
an extra 9000 £ to the NHS [3]. Despite the media focus on MRSA, numerous other pathogenic species have 
developed resistance, i.e. Vancomycin-Resistant Enterococci (VRE). SSTI incidence is 24.6 per 1000 person 
everyyear while among hospitalized patients the incidence is 7% to 10% [4]. The symptoms range from mild 
conditions, such as pyoderma, to serious life-threatening infections, such as necrotizing fasciitis. Microbial 
resistance can be originated by the cell altering the target of the drug without losing functionality (i.e. 
MRSA) through DNA mutations [5],[6].  
The prevention and treatment of infections can be through antibiotic drugs or no antibiotic based techniques; 
cold gas plasma, metal nanoparticles and Photodynamic therapy (PDT) are examples of the technologies that 
do not employ antibiotics to inactivate microorganisms. Photodynamic therapy  is a process based on the 
adsorption of photos by a photosensitiser (PS) and its transfer through a FRET (Förster resonance energy 
transfer) process (radiationless transfer of energy to neighbouring compound) to either oxygen (type 2 
reaction) or other substrates (type 1 reaction). The energy adsorption by the PS induces its transition from the 
ground state to an excited states (singlet or triplet), from these unstable states the PS return to the ground 
state transferring energy to oxygen molecules  forming reactive oxygen species (ROS) such as singlet 
oxygen (1O2) and other radicals (superoxide (O2• ) and OH•). ROS are then responsible for the oxidation of 
the substrate molecules [7]. Such potential cytotoxic activity of PDT has found applications in cancer 
treatments and as antimicrobial technique, so called antimicrobial PDT (aPDT); this has been possible 
because of the existence of biological safe PS (i.e. TBO, MB and indocyanine green) whose lethal dose to 
inactivate pathogenic microorganisms is smaller than mammalian cells [8],[9]. Another important benefit of 
aPDT is its efficacy against antibiotic resistant cells,  broad spectrum of action and  inability to induce 
further resistance in sensitive cells [10],[11]. All these virtues are due to the multi targets lethality 
mechanism of aPDT as ROS are unspecific in their interaction. The main applications of aPDT have been in 
dentistry [12] and dermatological set-ups [13], however, more recently, light activated materials have been 
developed as self-cleaning/self-sterilising surfaces with possible applications in catheters and open surfaces 
[14]-[21].  
As the threat posed by bacteria resistant to one or more antibiotics is a growing concern [22]-[25], the need 
for more effective antimicrobial techniques not based on antibiotic drugs i.e. aPDT is a pressing need. 
Nanotechnology has been applied to aPDT in order to enhance the antimicrobial outcome [7],[26], for 
example PS have been encapsulated in nanoparticles to guide their penetration inside cells or they have been 
conjugated to nanocarriers to drive their accumulation close to the cell wall. Among the nanocarriers used as 
drug delivery systems, silica has been widely used because of the ease of production and biological 
compatibility. Silica nanoparticles based treatments have been developed in cancer [27] and antimicrobial 
applications [28],[29].Silica nanoparticles loaded with antimicrobial compounds have been shown capable of 
reversing antibiotic resistance [29]-[32].  
In this work, TBO, a very common photosensitiser, has been bound to silica nanoparticles previously 
functionalised to exhibit amino groups. The physical-chemical properties of the nanoconjugates have been 
characterised and the antimicrobial activity against examples of Gram+ (S. epidermidis and MRSA) and 
Gram- (E. coli) pathogens determined. Furthermore, the TBO release has been shown to be pH dependent. 
  
2 Materials and methods 
2.1 Chemicals 
Toluidine Blue O (TBO), tetraethyl-orthosilicate (TEOS), 3-aminopropyltriethoxysilane (APTS), 2-(4-
morpholino)-ethane sulfonic acid (MES), suberic acid bis-(N-hydroxy-succinimide ester), Triton X-100, 
NaOH, Sodium dodecyl sulfate (SDS), MTT (3-(4,5-dimethythiazol-2yl)-2,5-diphenyltetrazolium bromide) 
Brain Heart Infusion (BHI) broth and Agar were purchased from Sigma-Aldrich. Ammonium hydroxide 
(29.6 %), cyclohexane, n-hexanol, isopropyl alcohol and methanol were purchased from Fisher Scientific. 
All chemicals were used as-received without further purification.  
2.2 Synthesis silica-TBO nanoconjugates 
Silica nanoparticles functionalised with amine groups (SiO2-NH2) were prepared in a one-pot synthesis by 
hydrolysis of TEOS in reverse microemulsion and subsequent surface functionalisation with amino groups 
[28]. Lastly, TBO molecules were covalently conjugated to the silica surface. 
In a typical synthesis, 17.7 g of Triton (X-100) were mixed with 16 ml of n-hexanol, 75 ml of cyclohexane, 
and 4.8 ml of deionised water under vigorous stirring. Once the solution became transparent, 600 μl of 
ammonium hydroxide were added to the solution. The solution was subsequently sealed and stirred for 20 
min, followed by addition of 1 ml of TEOS and stirring for 24 h. The silica nanoparticles surface was 
functionalised with amine groups adding 50 μl of APTS to the microemulsion under stirring and incubating 
for further 24 hours. The silica surface functionalised particles, denoted SiO2-NH2, were then recovered by 
adding ethanol (200 ml) to break the microemulsion and centrifuging at 14000 rpm for 10 min (LE-80K 
Ultracentrifuge, Beckman Coulter, UK) at 20 °C; the nanoparticles were then rigorously washed with 
methanol. 
The conjugation of TBO to SiO2-NH2 nanoparticles was carried out as follows: 50 mg of TBO were 
dissolved in 100 ml of MES buffer (0.1 M, pH 6.0); this solution was used to disperse 250 mg of SiO2-NH2 
and, finally, 50 mg of suberic acid bis-(N-hydroxysucciniimide ester) were added. The suspension was kept 
under vigorous mixing for 24 hours at room temperature in the dark and the conjugates were recovered 
centrifuging at 14000 rpm for 10 min (LE-80K Ultracentrifuge, Beckman Coulter, UK) at 20 °C. The silica-
TBO conjugates were washed three times in methanol and left to dry in the dark. 
2.3 Silica-TBO nanoconjugates characterisation 
Size and shape of the conjugates were determined through transmission electron microscopy (TEM); 4 µl 
droplet of conjugates suspension were deposited on a plain carbon-coated copper TEM grid, water was 
evaporated under ambient laboratory conditions for several hours. Bright field TEM images were obtained 
using a TEM (Philips CM12, FEI Ltd, UK) operating at 80kV fitted with an X-ray microanalysis detector 
(EM-400 Detecting Unit, EDAX UK) utilising EDAX’s Genesis software. Images (magnification of the 
images was x 100,000) were recorded using a SIS MegaView III digital camera (SIS Analytical, Germany) 
and analysed with ImageJ; the diameter of at least 100 particles was determined. 
Fourier-Transformed Infrared spectra (FTIR) of the samples were collected with Perkin Elmer Spectrum One 
with Ge/Ge UATR (wavenumber from 4000 to 600 cm−1). 
Thermogravimetric analysis (TGA) was performed using a Stanton Redcroft, STA-780 series TGA; data 
were recorded from 25 to 800 °C with a constant heating rate of 10 °C min-1. 
2.4 Antimicrobial activity of Si-TBO nanoconjugates 
The bacteria used in this study were E. coli (NCTC10418), methicillin-resistant Staphylococcus aureus 
MRSA (NCTC12493) and S. epidermidis (ATCC12228). They were stored at -80 °C; when needed they 
were plated on BHI agar and incubated for 24 hours at 37 °C. The plates were then kept at 4 °C for no more 
than 2 weeks. 10 ml of fresh sterile BHI broth in a 15 ml tube were inoculated with a loopful of cells from a 
single colony on a BHI plate; after incubating statically for 24 hours at 37 °C the cells suspension was 
diluted with sterile PBS 1:100. This cells suspension was used to disperse the Si-TBO conjugates to a 
concentration of 10 mg/ml; 200 l of this suspension were immediately poured in a 96 wells plate. The well 
was irradiated with the light (633 nm) from a 500 mW laser (BFi Optilas Ltd, UK) for 0.5, 1, 2 and 3 min; 
energy density (40 mW/mm2). After exposure, the bacterial cells (L+S+) were counted through serial 
dilutions in sterile PBS and plating on BHI Agar (plates were incubated 24 hours at 37 °C). Along this test 
(L+S+), control experiments were performed counting cells that were exposed, for the same length of time, 
to laser light without conjugates (L+S-). Cells were also stored in the dark with (L-S+) and without the silica 
conjugates (L-S-). The tests were performed on three independent cultures on conjugates from three 
independent batches. 
Additionally, a TBO solution 30 mg/ml was prepared in PBS and filter sterilised; this solution was diluted 
using the bacterial suspensions (106 CFU/ml in PBS) prepared as described above to a final concentration of 
TBO of 300 mg/l. 200 l of this suspension was immediately poured in a 96 wells plate. The well was 
irradiated with the light (633 nm) from a 500 mW laser (BFi Optilas Ltd, UK) for 0.5, 1, 2 and 3 min; energy 
density (40 mW/mm2). After exposure the bacterial cells (L+S+) were counted through serial dilutions in 
sterile PBS and plating on BHI Agar (plates incubated 24 hours at 37 °C). The tests were performed on three 
independent cultures. 
2.5 Bacterial uptake of TBO 
10 mL of fresh sterile BHI broth were inoculated with a loopful of cells from a single colony on a BHI plate 
and incubated aerobically for 24 h at 37°C statically. The bacterial suspension was then centrifuged with an 
Avanti J-20XP Centrifuge (Beckmann and Coulter, United States) for 3 min at 2938 g, afterwards the 
supernatant was disposed. After one wash with PBS and centrifugation (3 min at 2938 g), 1 mL of Si-TBO 
suspension in PBS (10 mg/ml) or pure TBO (300 mg/l) was added to the precipitated cells. The resulting 
solution was vortexed and incubated 3 min at 37°C statically. The suspension was passed through a filter 
with 0.45 m pores to separate the cells from the particles. The filter was washed in PBS and the cells 
centrifuged (3 min at 2938 g). 
After discharging the supernatant, the cells were dissolved in 1 mL 0.1 M NaOH/1% Sodium dodecyl sulfate 
(SDS) and incubated at 37°C for 24 h to lyase the cells and release the TBO. The optical density of samples 
was measured at a 650 nm using a plate reader (Labtech LT5000MS) against a calibration curve prepared 
using the corresponding bacterial lysate. 
The protein content of the entire cell extracts was determined for each culture by a modified Lowry method 
using bovine serum albumin (BSA) dissolved in 0.1 M NaOH/1% SDS to construct calibration curves. The 
tests were performed on three independent cultures and results are expressed as nmol of TBO/mg of cell 
protein. 
2.6 Cytocompatibility of Si-TBO nanoconjugates 
Human fibroblasts (MRC-5) were cultured in RPMI-1640 medium supplemented with glutamine, 10% FBS 
and 1% pen-strep, in a humidified incubator at 37 °C and 5% CO2. When about 70% confluence was 
reached, fibroblasts were washed in sterile PBS and trypsinated. 96 well plates were the inoculated with 
approximately 6000 cells/well in 200 l of media, plates were incubated in a humidified incubator at 37 °C 
and 5% CO2. After 2 days the medium was removed and cells were washed in sterile PBS; 200 l of Si-TBO 
conjugates suspension in PBS at a concentration of 10 mg/ml were poured in a 96 wells plate. The well was 
irradiated with the light (633 nm) from a 500 mW laser (BFi Optilas Ltd, UK) for 3 min; energy density (40 
mW/mm2) (L+S+) or kept in the dark for the same length of time (L-S+). Control samples were also 
prepared adding 200 l of pure sterile PBS to the wells and either irradiated (L+S-) or kept in the dark (L-S-
).  
Fibroblast viability was assessed through MTT (3-(4,5-dimethythiazol-2yl)-2,5-diphenyltetrazolium 
bromide) assay. After exposure to laser or storage in the dark the suspension in the wells was replaced with 
phenol red-free medium and 50 µl of MTT stock solution (5 mg/ml) was added to each well and incubated at 
37°C in humidified atmosphere containing 5% CO2 for 4 hour. The metabolised MTT, formazan, was re-
suspended with 50 µl of dimethyl sulfoxide (DMSO). 200 µl were transferred to a 96-well plate absorbance 
at 560 nm was read using a spectrophotometer (ELISA Reader Labtech LT-5000MS). All experiments were 
performed in triplicates. 
2.7 TBO release from conjugates 
TBO release was quantified dispersing conjugates (5 mg) in citric acid - Na2HPO4 buffers pH = 7, 6, 5 and 4 
(1 ml); the suspension was incubated at 37 °C in Eppendorfs. At prefixed times, the suspension was 
centrifuged at 5087 g (Multifuge 3 S-R, Heraeus) for 5 min and samples were taken (200 l) from the 
supernatant. TBO in the buffer was quantified through adsorption at 630 nm (FLUOROstar Optina, BMG 
labtech); standards of known TBO in each buffer were also analysed simultaneously to provide pH-
dependent calibration. After analysis the samples were added back to the original Eppendorf and the 
nanoparticles suspended. The tests were performed in duplicates on conjugates from three independent 
batches. 
 
3 Results and discussion 
3.1 Conjugates characterisation 
The synthesis of the silica nanoparticles was carried out using the widely employed Stöber method that is 
based on the hydrolysis of TEOS in an alkaline solution [33]. The silica unconjugated nanoparticles (SiO2-
NH2) were roundly shaped as seen in TEM images (Figure 2a) and the diameter was narrowly distributed (57 
± 9 nm) as seen in Figure 2b; the conjugation of TBO did not have impact on the shape (Figure 2c) and 
diameter of the nanoparticles (Figure 2d) that was 59 ± 7 nm.  
The Stober process allows the formation of silica nanoparticles of a wide size range 2 to 2000 nm through 
the control of the reaction conditions [34]; we employed parameters similar to Guo et al. 2010 [28] that 
reported the formation of nanoparticles with diameter ranging from 50 to 80 nm, very close to our results.   
The FTIR spectra in Figure 3 showed strong adsorption peaks at about 1100 cm−1 for all the nanoparticles; 
these are related to Si-O-Si stretching vibration of silanol groups. The presence of -CH2 groups was 
confirmed by C-H stretching at 2926 cm−1 and C-H scissoring vibration at 1456 cm−1. N-H stretching is 
responsible for the peaks between 3200 and 3400 cm−1 confirming the presence of NH2 on the silica 
functionalised nanoparticles. These FTIR spectra are similar to those presented by Li et al. 2012 [35]. 
Moreover, the FTIR spectra did not show evidence of TBO on the surface (Figure 3) and this was probably 
connected to the low amount of dye bound on the surface.  
Both type of nanoparticles (unconjugated and conjugated) started to lose mass when heated at about 200°C 
consistent with the oxidation of organic matter present. The unconjugated particles exhibited a lower mass 
reduction (about 8%) than the conjugated at 800 °C when it can be assumed that only the inorganic fraction 
of the nanoparticles is left. The TBO load on the nanoparticles was determined as the difference between the 
organic fraction  of unconjugated and conjugated samples, this was estimated to be around 3-4 % w/w. 
Similar loads on nanoparticles through conjugation on the surface of functionalised nanoparticles were 
reported in other works [36]-[38]. 
3.2 Photosensitisation of bacteria and fibroblasts 
The number of viable cells of E. coli, MRSA and S. epidermidis exposed to laser light in the presence of Si-
TBO nanoparticles decreased with increasing exposure time (Figure 5). After 3 min of laser irradiation, E. 
coli exhibited a reduction of about 2 log10 whilst S. epidermidis returned the same level of inactivation after a 
shorter period of irradiation (2 min), when the irradiation was conducted for 3 min the number of viable cells 
fell below the detection limit. Also the number of viable MRSA cells after laser irradiation in the presence of 
the silica-TBO nanoconjugates decreased with increasing treatment time; generally the inactivation of 
MRSA was lower than S. epidermidis and greater than E. coli. Moreover, for all three bacterial species 
tested, the inactivation resulting from the exposure to pure TBO (at a concentration equivalent to that of 
silica-TBO nanoconjugates) was lower than in the case of silica-TBO nanoconjugates for analogous 
irradiation times (Figure 5). 
For all three bacterial species no inactivation was detected when cells were exposed to laser light without the 
presence of Si-TBO nanoparticles (L+S-) or when in contact with the nanoparticles without  irradiation (L-
S+) demonstrating the non bactericidal activity of either the laser or the nanoparticles individually but the 
necessary synergistic interaction. These results are the common pattern in aPDT and are the consequence of 
the physical mechanism of PDT (the interaction between photons and photosensitisers) and also highlight the 
lack cytotoxicity of the Si-TBO nanoparticles developed in this work. Furthermore, the greater resistance to 
aPDT inactivation found in this wok for E. coli compared to S. epidermidis and MRSA is in agreement with 
the relatively well known lower susceptibility of Gram- bacteria to this technology than Gram+ that has been 
linked to the different cell wall structure characterising these two classes of bacteria. The species used in this 
work were chosen as they are common representative of pathogens present on the skin [39] and routinely 
employed to test sanitation processes. 
The amount of TBO found inside the bacterial cells increased when the nanocojugates were employed 
(Figure 7) compared to exposure to the corresponding amount of dye in its free form. Moreover, Gram+ 
bacteria uptake of the dye was higher than E. coli; this can be attributed to the different cell wall structure 
that is well known to reduce Gram- staining. The higher inactivation kinetics of the two Gram+ positive 
species tested than E. coli (Gram-) is linked to the different uptake of the dye; in addition our results suggest 
that the improved lethality observed for the Si-TBO nanoconjugates could be a consequence of the enhanced 
cell uptake of the photosensitiser. It has been suggested that local concentrations of antimicrobial agents, 
through the conjugation on nanoparticles surfaces, is a method to enhance antimicrobial efficacy focusing the 
activity in locations close or inside cells; this spatial disuniformity could only be achieved through drug 
delivery systems otherwise molecules would uniformly distribute [30],[40],[41].  
The Si-TBO nanoconjugates prepared in this work did not impact on fibroblasts viability either in the dark or 
in conjunction with laser irradiation for 3 min (Figure 6), demonstrating that the Si-TBO nanoconjugates did 
not present cytotoxic properties towards mammalian cells, at least for the laser irradiation time sufficient to 
inactivate pathogenic bacteria. It is well established that mammalian cells are generally more resistant to the 
ROS produced by PDT than bacteria [8],[9]; this provides the foundation for aPDT as treatments are dosed 
to provide bacteria killing but not to result in mammalian cells damage. Our results were expected and they 
are in agreement with the established knowledge. 
 3.3 pH dependent photosensitiser release from conjugates 
TBO was released from the conjugated when in contact with a liquid phase (Figure 8). The amount of TBO 
released increased with time following a Fickian profile; the pH of the buffer was critical in determining the 
kinetic, the more acidic pH gave quicker release than the neutral; no statistical difference was recorded 
between pH = 5 and 6. The concentration of TBO in the buffer containing Si-TBO continued increasing TBO 
for at least 48 hours in case of acid condition, whilst did not increase after the first 4 hours for neutral 
conditions. 
The conjugation of TBO to the silica nanocarriers is performed through the formation of an amide bond; 
therefore, it was expected that acidic condition would favour the hydrolysis of this link hence increasing the 
TBO release. Additionally, the amount of photosensitiser detached from the carriers at neutral pH was very 
small highlighting the strength of the bond formed. 
Silica nanoparticles loaded with photosensitiser can be prepared also through the direct entrapment of the 
dye inside the nanoparticles during the synthesis [42], however such approach leads to a very quick release 
of the light activated compound  in a pH uncontrolled manner. 
 
4 Conclusions 
We photoactivated silica nanoparticles through binding TBO to the previously functionalised nanoparticles, 
these conjugates exhibit pH responsive release of the photosensitisers and antimicrobial activity when 
irradiated. The enhanced antimicrobial activity of the Si-TBO nanoconjugates, following laser irradiation, 
appeared correlated to increased bacterial cell uptake of the dye. 
These conjugates can be employed to prepare materials such as hydrogels and topical creams that exhibit 
light dependant antimicrobial activity; moreover the use of silica supported TBO, instead of the free drug, 
enables the formulation of nanocomposites with enhanced mechanical properties accompanying the light 
activated antimicrobial activity and provides a pH responsive drug delivery system. 
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Figure captions 
 
Figure 1. Reaction scheme of the preparation of silica nanoparticles and TBO conjugation. 
 
Figure 2. Example of TEM image (a) and size distribution (b) of Silica nanoparticles before TBO 
conjugation and after TBO binding (c and d). 
 
Figure 3.  Fourier Transformed Infrared spectra (FTIR) of silica conjugates from 4000 to 600 cm-1.  
 TBO     SiO2-TBO    SiO2-NH2    
 
Figure 4. Mass loss during Thermal Gravimetric Analysis (TGA) of Silica nanoparticles and silica 
photosensitiser conjugates. 
 SiO2-NH2   SiO2- TBO  
 
Figure 5. Time dependent antimicrobial activity of Silica-TBO conjugates against (a) E. coli and (b) S. 
epidermidis and MRSA (c) after exposure to red laser (630 nm).   
 L+S+   L+S-  L-S+  L-S-   L+ pure TBO 
 
Figure 6. Viability of fibroblast determined using MTT assay after exposure to Si-TBO nanoconjugates and 
red laser irradiation. 
 
Figure 7. Bacterial cells uptake of TBO using either Si-TBO nanoconjugates (grey columns) or an equivalent 
photosensitisers amount in pure form (black columns). 
 
Figure 8. Release profiles of TBO from SiO2-TBO nanoconjugates in buffers of various pH. 
 pH = 4   pH = 5 pH = 6  pH = 7  
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